Assembly Bill 555 would prohibit private insurance companies from charging people more than $35 for a 30-day supply of a ...

Using a glass vial and needle is one of the most common ways of taking insulin. It may help you avoid the additional costs tied to prefilled insulin pens or expensive diabetes pump devices.

India's CDSCO grants approval for Afrezza, an inhalable insulin spray, offering a needle-free alternative for diabetes management Afrezza provides a rapid, needle-free solution, ideal for patients ...

Novo Nordisk and Sanofi are facing an investigation in South Africa over concerns about potential anti-competitive practices in the human insulin pen market. South Africa's Competition Commission said ...

This move is a milestone, he noted, as for the first time insulin is being produced as pens inside Egypt, after it was previously produced only in the form of injections. This achievement reflects ...

Pens are easier and more precise to use than syringes for injecting insulin. Some diabetes patients in the U.S. have this year pushed back against the company's decision to stop selling its long ...

Uptake of insulin pens in LMICs is lower. A 2019 survey found 17% of diabetes centers in LMICs were using pens. Syringes remained the dominant delivery format and almost all countries reused needles.

Dr. Mbangata said insulin pens, which were more accurate, user-friendly and associated with less pain when used with short and fine needles, significantly enhanced their quality of life.

Insulin therapy is essential for managing diabetes. It includes various methods such as basal-bolus, fixed-dose, pump, pen, and inhaler therapies. These therapies help control blood sugar levels ...

A pen can be set with a dial to dispense a given amount of insulin, and its needle tip can be quickly jabbed into the skin. Insulin from a vial has to be drawn out into a syringe with the patient ...

“My lab has been working on needle-free insulin alternatives these past three years,” professor Shyh-Dar Li said, with UBC Pharmaceutical Sciences. “We tried nasal sprays before landing on ...

The Swiss diabetes hardware company Ypsomed is selling off its insulin pen needle and blood sugar monitoring operations, as it turns its attention toward its drug autoinjectors and digital insulin ...